• Harun Kundi, ÇetinElif Hande ÖzcanEHÖAnkara City Hospital, Department of Cardiology, Ankara, Turkey., Uğur Canpolat, Sevgi Aras, Osman Celik, Naim Ata, Suayip Birinci, Serkan Çay, Özcan Özeke, Ibrahim Halil Tanboğa, and Serkan Topaloğlu.
• Ankara City Hospital, Department of Cardiology, Ankara, Turkey. Electronic address: harunkundi@hotmail.com.
• J. Infect. 2020 Dec 1; 81 (6): 944-951.

BackgroundDiagnosis and screening of frailty, a condition characterized by an increased vulnerability to adverse outcomes of COVID-19, has emerged as an essential clinical tool which is strongly recommended by healthcare providers concerned with hospitalized elderly population. The data showing the role of frailty in patients infected with COVID-19 is needed.MethodsThis was a nationwide cohort study conducted at all hospitals in Turkey. All COVID-19 hospitalized patients (≥ 65 years) were included. Patients who were alive and not discharged up to July 20, 2020, were excluded. The frailty was assessed by using the "Hospital Frailty Risk Score" (HFRS). Patients were classified into three risk groups of frailty based on previously validated cut points as low (<5 points), intermediate (5-15 points), and high (>15 points). Additionally, patients who had the HFRS of ≥5 were defined as frail. The primary outcome was in-hospital mortality rates by frailty group.ResultsBetween March 11, 2020, and June 22, 2020, a total of 18,234 COVID-19 patients from all of 81 provinces of Turkey were included. Totally, 12,295 (67.4%) patients were defined as frail (HFRS of >5) of which 2,801 (15.4%) patients were categorized in the highest level of frailty (HFRS of >15). Observed in-hospital mortality rates were 697 (12.0%), 1,751 (18.2%) and 867 (31.0%) in low, intermediate and high hospital frailty risk, respectively (p<0.001). Compared with low HFRS (<5), the adjusted odds ratios for in-hospital mortality were 1.482 (1.334-1.646) for intermediate HFRS (5-15) and 2.084; 95% CI, 1.799-2.413 for high HFRS (>15).ConclusionsAs a claims-based frailty model, the HFRS provides clinicians and health systems, a standardized tool for an effective detection and grading of frailty in patients in COVID-19. A frailty-based tailored management of the older population may provide a more accurate risk categorization for both therapeutic and preventive strategies.Copyright © 2020 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

28 keywords...

hide…